Astronics Corp: Form 10-K for the period ended Dec 31, 2023
Filed with the SEC on Mar 5, 2024 and accepted by EDGAR at Mar 4, 2024, 22:33 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-10-01 to 2023-12-31 | $195.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 12 months2023-01-01 to 2023-12-31 | $689.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2023-01-01 to 2023-12-31 | $568.4m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2023-10-01 to 2023-12-31 | $40.0m | us-gaap:GrossProfit |
| Gross profit | 12 months2023-01-01 to 2023-12-31 | $120.8m | us-gaap:GrossProfit |
| Research and development | 12 months2023-01-01 to 2023-12-31 | $53.5m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2023-01-01 to 2023-12-31 | $127.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2023-01-01 to 2023-12-31 | −$6.7m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2023-01-01 to 2023-12-31 | $110.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-10-01 to 2023-12-31 | $7.0m | us-gaap:NetIncomeLoss |
| Net income | 12 months2023-01-01 to 2023-12-31 | −$26.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-10-01 to 2023-12-31 | $0.20 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2023-01-01 to 2023-12-31 | −$0.80 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-10-01 to 2023-12-31 | $0.20 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2023-01-01 to 2023-12-31 | −$0.80 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2023-01-01 to 2023-12-31 | 33,104,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2023-01-01 to 2023-12-31 | −$23.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2023-01-01 to 2023-12-31 | $7.6m | us-gaap:PaymentsToAcquireProductiveAssets |
| Cash and equivalents | At period end2023-12-31 | $4.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-12-31 | $389.8m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-12-31 | $633.8m | us-gaap:Assets |
| Current liabilities | At period end2023-12-31 | $143.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-12-31 | $384.3m | us-gaap:Liabilities |
| Long-term debt | At period end2023-12-31 | $159.2m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2023-12-31 | $9.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2023-12-31 | $249.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000008063-24-000014. Last ingested by Listed: Oct 24, 2026, 14:51 ET. Listed shows no prices and gives no investment advice.